Axon Biotech GmbH
DE-MF-000027334 · Germany · Hengersberg
Axon Biotech GmbH is registered in the European database on medical devices as a manufacturer, with 79 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
Most frequent device types declared: AL0202.
Among these devices, 3 are declared sterile.
Devices declared under this manufacturer
- NaCl 0,85%
- ProbeAX Evolution
- ProbeAX Evolution Blister
- R2 AxonGram
- R4 AxonGram
- StorAX Cary Blair
- StorAX Nativ
- StorAX SAF
- Uritube E
- VRE Anreicherungsbouillon
- VTM 1ml
- VTM 3ml
Showing 12 of 79 declared devices.
Catalogue references include AL0101_950, AL0132, AL0301ME, AL0301_500, AL0302_250, AL0604_1,0.
European nomenclature codes declared: W05020199, W0104010804, W0104010703, W0104010299, W0104010203, W0104010499.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 79 |
| Country of registration | Germany |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 79 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. Axon Biotech GmbH was not found in either the U.S. or the Canadian register.